Your browser doesn't support javascript.
loading
Advances in the application of traditional Chinese medicine during the COVID-19 recovery period: A review.
Zhang, Weixin; Ma, Linlin; Xie, Wei; Li, Xingxing; Zhang, Juhua; Sun, Ji.
Affiliation
  • Zhang W; Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Ma L; School of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Xie W; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Li X; School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Zhang J; Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Sun J; Collaborative Innovation Center for Biomedicines, Shanghai University of Medicine and Health Sciences, Shanghai, China.
Medicine (Baltimore) ; 103(14): e37683, 2024 Apr 05.
Article in En | MEDLINE | ID: mdl-38579075
ABSTRACT
Since the emergence of the Coronavirus Disease 2019 (COVID-19) outbreak, significant advancements has been made in research, from limited knowledge about the disease to the development of a vaccine. Although the severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appears to be decreasing and the threat of COVID-19 is waning, there have been widespread concerns about persistent symptoms or sequelae experienced by some patients even after recovering from COVID-19. Traditional Chinese medicine (TCM) has shown favorable treatment outcomes during the onset of COVID-19, and extensive studies have been carried out to explore the efficacy of TCM interventions during the COVID-19 recovery period. The purpose of this review is to comprehensively analyze these studies and provide new insights for the prevention and treatment of the post-COVID-19 condition.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / COVID-19 Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / COVID-19 Limits: Humans Language: En Journal: Medicine (Baltimore) Year: 2024 Document type: Article Affiliation country: